Skip to main content

Table 2 Univariate and multivariate analysis of possible factors associated with low serum phosphorus at week 24 after switching NRTI

From: Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

Parameters

Univariate analysis

Multivariate analysis

 

Beta

95%CI of Beta

P value

Beta

95%CI of Beta

P value

Receiving efavirenz

0.320

0.099 to 0.739

0.011

0.321

0.098 to 0.714

0.011

Age

-0.434

-0.056 to -0.017

<0.001

-0.329

-0.049 to -0.006

0.015

Serum phosphorus at week 0

0.423

0.164 to 0.720

0.002

0.298

0.023 to 0.599

0.035

Negative HBsAg

-0.231

-1.278 to 0.054

0.071

0.070

-0.458 to 0.826

0.567

Female gender

0.237

-0.020 to 0.671

0.064

0.037

-0.306 to 0.405

0.781